सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

BRIC-RGCB receives ₹7 crore grant to develop automated blood-based cervical cancer diagnostic device

GS3Economy · S&T · Environment · Security· Biotechnology & health research· Prelims·

Public-private partnerships in biotechnology: a key GS3 Science & Technology and healthcare innovation case.

Why in news

The Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) received a ₹7 crore grant from the MAHA MedTech Mission to develop an automated blood-based cervical cancer diagnostic device.

Background

The project is supported by the Anusandhan National Research Foundation (ANRF), Indian Council of Medical Research (ICMR), and the Gates Foundation. The development involves collaboration between BRIC-RGCB, IndZita Biotech Private Limited, and Karkinos Healthcare Private Limited (KHPL).

Facts for Prelims

  • FactGrant amount: ₹7 crore for automated blood-based cervical cancer diagnostic device
  • BodyANRF: Anusandhan National Research Foundation
  • BodyICMR: Indian Council of Medical Research
  • BodyMAHA MedTech Mission: Supporting body for the grant

Prelims practice question

With reference to the development of the automated blood-based cervical cancer diagnostic device, consider the following statements:

  1. The project receives a grant of ₹7 crore from the MAHA MedTech Mission.
  2. The development is supported by the Indian Council of Medical Research (ICMR).
  3. The project is funded exclusively by the Gates Foundation without any government involvement.

Which of the statements given above is/are correct?

  1. (a)1 only
  2. (b)1 and 2 only
  3. (c)2 and 3 only
  4. (d)1, 2 and 3
Show answer

Answer: (b) 1 and 2 only — Statements 1 and 2 are correct. Statement 3 is incorrect: The project is also supported by ANRF and ICMR.

For Mains

Q. Discuss how public-private partnerships and multi-institutional funding models can accelerate the development of affordable diagnostic technologies for non-communicable diseases in India.

Dimensions to cover in your answer

  • Diagnostic accessibility: Reducing reliance on invasive procedures through non-invasive blood-based screening
  • Funding synergy: Leveraging multi-agency support (ANRF, ICMR, Gates Foundation) to bridge R&D funding gaps
  • Commercialization pathway: Integrating private biotech firms to scale laboratory innovations into clinical tools

Keywords: Public-Private Partnership · Diagnostic Innovation · Biotechnology · Non-communicable Diseases · Medical Research

Read the full news →Report a mistake in this noteHow notes are madeSource: The Hindu ↗Also: GS2 · Health policy & public healthAlso: GS2 · Government policies & schemes

More Science & Technology notes

All Science & Technology current affairs →

Something wrong, or something missing?

Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.

Report a mistake →Ask for something →[email protected]

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.